The estimated Net Worth of David A Jr/Ky Jones is at least $53.6 Milion dollars as of 21 December 2022. Mr. Jones owns over 15,000 units of Humana stock worth over $13,793,169 and over the last 21 years he sold HUM stock worth over $39,427,724. In addition, he makes $427,405 as Independent Director at Humana.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Jones HUM stock SEC Form 4 insiders trading
David has made over 29 trades of the Humana stock since 2005, according to the Form 4 filled with the SEC. Most recently he sold 15,000 units of HUM stock worth $7,525,800 on 21 December 2022.
The largest trade he's ever made was selling 150,000 units of Humana stock on 23 February 2011 worth over $9,550,500. On average, David trades about 9,316 units every 95 days since 2004. As of 21 December 2022 he still owns at least 42,028 units of Humana stock.
You can see the complete history of Mr. Jones stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Jones biography
David A. Jones Jr. serves as Independent Director of the Company. He was initially elected to the Board in May 1993 and served as Chairman of the Board of the Company from April 2005 through August 2010, and Vice Chairman of the Board from September 1996 through April 2005. He is Chairman of Chrysalis Ventures, LLC, headquartered in Louisville, Kentucky, and also serves on the board of directors of several charitable, civic and privately held companies. As a successful venture capitalist, the Board believes that Mr. Jones brings strategic insight and leadership and a wealth of experience in health care to the Board, both in the Company’s core businesses as well as in emerging technologies and business models.
What is the salary of David Jones?
As the Independent Director of Humana, the total compensation of David Jones at Humana is $427,405. There are 11 executives at Humana getting paid more, with Bruce Broussard having the highest compensation of $16,726,500.
How old is David Jones?
David Jones is 70, he's been the Independent Director of Humana since 2010. There are no older and 30 younger executives at Humana.
What's David Jones's mailing address?
David's mailing address filed with the SEC is CHRYSALIS VENTURES, INC., 101 S. FIFTH STREET, SUITE 1650, LOUISVILLE, KY, 40202.
Insiders trading at Humana
Over the last 21 years, insiders at Humana have traded over $407,571,978 worth of Humana stock and bought 48,042 units worth $3,529,357 . The most active insiders traders include Brad D Smith, Frank A Damelio a Frank Bisignano. On average, Humana executives and independent directors trade stock every 12 days with the average trade being worth of $6,532,294. The most recent stock trade was executed by George Ii Renaudin on 1 September 2024, trading 1,241 units of HUM stock currently worth $407,284.
What does Humana do?
at humana, our cultural foundation is aligned to helping members achieve their best health by delivering personalized, simplified, whole-person healthcare experiences. recognizing healthcare needs continue to evolve for each person, for each family and for each community, humana continuously creates innovative solutions and resources that help people live their healthiest lives on their terms –when and where they need it. our employees are at the heart of making this happen and that’s why we are dedicated to building an organization of dynamic talent whose experience and passion center on putting the customer first.
What does Humana's logo look like?
Complete history of Mr. Jones stock trades at Humana
Humana executives and stock owners
Humana executives and other stock owners filed with the SEC include:
-
Bruce Broussard,
President, Chief Executive Officer, Director -
Brian Kane,
Chief Financial Officer -
Bruce Dale Broussard,
Pres, CEO & Director -
Christopher Hunter,
Segment President, Group and Military Business -
Alan Wheatley,
Segment President - Retail -
Timothy Huval,
Chief Administrative Officer -
William Fleming,
Segment President, Clinical and Pharmacy Solutions -
Timothy S. Huval,
Chief Admin. Officer -
T. Alan Wheatley,
Segment Pres of Retail -
Dr. William Kevin Fleming Pharm.D., PharmD, RPh,
Chief Corp. Affairs Officer & Segment Pres, Pharmacy Solutions -
Kurt Hilzinger,
Independent Chairman of the Board -
David Jones,
Independent Director -
James O'Brien,
Independent Director -
Frank Bisignano,
Independent Director -
William McDonald,
Independent Director -
Karen Katz,
Independent Director -
Frank D'Amelio,
Independent Director -
Marissa Peterson,
Independent Director -
Amy Smith,
Vice President, Investor Relations -
John Garratt,
Independent Director -
Wayne Frederick,
Independent Director -
Raquel Bono,
Independent Director -
Joseph Ventura,
Chief Legal Officer -
William Shrank,
Chief Medical and Corporate Affairs Officer -
Heather Carroll,
Chief Digital Health and Analytics Officer -
Vishal Agrawal,
Chief Strategy and Corporate Development Officer -
Sam Deshpande,
Chief Technology Officer, Chief Risk Officer -
Cynthia Zipperle,
Senior Vice President, Chief Accounting Officer, Controller -
Susan Diamond,
Segment President, Home Business -
Joseph C. Ventura,
Chief Legal Officer -
Lisa M. Stoner,
VP of Investor Relations -
Sam M. Deshpande,
Chief Information Officer -
Cynthia Hillebrand Zipperle,
Sr. VP, Chief Accounting Officer & Controller -
Susan Marie Diamond,
CFO & Segment Pres of Home Bus. -
Amy Fry,
Sr. VP of Corp. Communications -
Michael A. Koeberlein,
SVP, Chief Accting Off & Cont. -
Heather Cox,
Chief Dig Health & Analyt Off. -
Christopher E Kay,
SVP & Chief Innovation Officer -
Webster Roy Dunbar,
Director -
James E Murray,
COO-Mkt & Bus. Segment Ops -
Roy A Beveridge,,
Sr. VP & Chief Medical Officer -
Joseph William Jasser,
President, Care Delivery -
M Todoroff Christopher,
Sr. VP and General Counsel -
Jody L Bilney,
Chief Consumer Officer -
Heidi S Margulis,
Senior V.P.-Gov. Relations -
Steven E Mc Culley,
Vice President & Controller -
David Nash,
Director -
William Mitchell,
Director -
Karen B De Salvo,
Director -
Jorge S. Mesquita,
Director -
Marcy S Klevorn,
Director -
Thomas J Liston,
Sr VP-Strategy & Corp Dev -
Michael B Mccallister,
President & CEO -
Elizabeth D Bierbower,
Strategic Advisor -
James H Bloem,
Sr. VP, CFO & Treasurer -
Bruce D Perkins,
Sgmnt Pres, Health&Well-Being -
Tim S Mc Clain,
Group Pres, Govt & Other Busin -
Paul B. K. Kusserow,
Sr VP & Ch Strat Dev Officer -
Venkata R Madabhushi,
SVP & Chief Innov & Mrkting Of -
Bonnie C Hathcock,
Sr VP & Chief Human Res. Off -
W Ann Reynolds,
Director -
Jonathan T Md Lord,
Sr VP & Chief Innovation Off. -
Bruce J Goodman,
Sr VP & Chief Serv. & Info. Of -
Kathleen Pellegrino,
VP and Acting General Counsel -
James O Robbins,
Director -
Steven O Moya,
Sr. VP-Chief Marketing Officer -
Arthur P Hipwell,
Sr VP & General Counsel -
John M Bertko,
Vice President & Chief Actuary -
Michael E Gellert,
Director -
David A Sr/Ky Jones,
Director -
John R /Ky Hall,
Director -
R Eugene Shields,
Senior Vice President-Gov Prgm -
Irwin Lerner,
Director -
Brian P. Le Claire,
Strategic Advisor -
Susan D. Schick,
Seg Pres. Grp. & Military Bus. -
David T Feinberg,
Director -
M.D. Andrew C. Agwunobi,,
Seg. President, Home Solutions -
John Paul W. Felter,
SVP, Chief Accting Off & Cont. -
Brad D Smith,
Director -
George Ii Renaudin,
President, Medicare & Medicaid -
Sanjay K Shetty,
President, CenterWell -
David Dintenfass,
President, Enterprise Growth -
James A. Rechtin,
President & COO